Manifesto for a European anxiety disorders research network

David S. Baldwin; Christer Allgulander; Alfredo Carlo Altamura; Jules Angst; Borwin Bandelow; Johan den Boer; Patrice Boyer; Simon Davies; Bernardo dell'Osso; Elias Eriksson; Naomi Fineberg; Mats Fredrikson; Andres Herran; Eduard Maron; Andres Metspalu; David Nutt; Nic van der Wee; Jose Luis Vázquez-Barquero; Joseph Zohar

doi:10.1016/j.euroneuro.2010.02.015

Manifesto for a European anxiety disorders research network

David S. Baldwin^*, Christer Allgulander, Alfredo Carlo Altamura, Jules Angst, Borwin Bandelow, Johan den Boer, Patrice Boyer, Simon Davies, Bernardo dell'Osso, Elias Eriksson, Naomi Fineberg, Mats Fredrikson, Andres Herran, Eduard Maron, Andres Metspalu, David Nutt, Nic van der Wee, Jose Luis Vázquez-Barquero, Joseph Zohar

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

24 Scopus citations

Abstract

Despite the size, burden and costs of anxiety disorders, many patients remain unrecognised, and the effectiveness of evidence-based interventions in routine clinical practice can be disappointing. The European College of Neuropsychopharmacology (ECNP) has established the ECNP Network Initiative (ECNP-NI) to help meet the goal of extending current understanding of the causes of central nervous system disorders, thereby contributing to improvements in clinical outcomes and reducing the associated societal burden. The Anxiety Disorders Research Network (ADRN) has been adopted within the ECNP-NI: this consensus statement summarises its overall aims and objectives.

Original language	English
Pages (from-to)	426-432
Number of pages	7
Journal	European Neuropsychopharmacology
Volume	20
Issue number	6
DOIs	https://doi.org/10.1016/j.euroneuro.2010.02.015
State	Published - Jun 2010
Externally published	Yes

Funding

Funders	Funder number
ECNP-NI
FP7 projects ECOGENE
OPENGENE
ExxonMobil Research and Engineering Company	SF 0180142
European Commission
European College of Neuropsychopharmacology

Keywords

Anxiety disorders
Outcomes
Research network
Treatment

Access to Document

10.1016/j.euroneuro.2010.02.015

Cite this

Baldwin, D. S., Allgulander, C., Altamura, A. C., Angst, J., Bandelow, B., den Boer, J., Boyer, P., Davies, S., dell'Osso, B., Eriksson, E., Fineberg, N., Fredrikson, M., Herran, A., Maron, E., Metspalu, A., Nutt, D., van der Wee, N., Vázquez-Barquero, J. L., & Zohar, J. (2010). Manifesto for a European anxiety disorders research network. European Neuropsychopharmacology, 20(6), 426-432. https://doi.org/10.1016/j.euroneuro.2010.02.015

@article{32e11e2243ef4c4fa43c65d8890a736a,

title = "Manifesto for a European anxiety disorders research network",

abstract = "Despite the size, burden and costs of anxiety disorders, many patients remain unrecognised, and the effectiveness of evidence-based interventions in routine clinical practice can be disappointing. The European College of Neuropsychopharmacology (ECNP) has established the ECNP Network Initiative (ECNP-NI) to help meet the goal of extending current understanding of the causes of central nervous system disorders, thereby contributing to improvements in clinical outcomes and reducing the associated societal burden. The Anxiety Disorders Research Network (ADRN) has been adopted within the ECNP-NI: this consensus statement summarises its overall aims and objectives.",

keywords = "Anxiety disorders, Outcomes, Research network, Treatment",

author = "Baldwin, {David S.} and Christer Allgulander and Altamura, {Alfredo Carlo} and Jules Angst and Borwin Bandelow and {den Boer}, Johan and Patrice Boyer and Simon Davies and Bernardo dell'Osso and Elias Eriksson and Naomi Fineberg and Mats Fredrikson and Andres Herran and Eduard Maron and Andres Metspalu and David Nutt and {van der Wee}, Nic and V{\'a}zquez-Barquero, {Jose Luis} and Joseph Zohar",

note = "Funding Information: The ECNP Network Initiative (ECNP-NI) is supported financially by the ECNP. The Anxiety Disorders Research Network is one component of the ECNP-NI and has received funding from the ECNP-NI to support its initial development. Funding Information: The ECNP Network Initiative (ECNP-NI) is supported financially by the ECNP. The Anxiety Disorders Research Network is one component of the ECNP-NI and has received funding from the ECNP-NI to support its initial development. David Baldwin is the Chair of the ADRN and makes the following declaration: declarations from the other 18 members of the ADRN do not accompany this manuscript but would be made available upon request. ",

year = "2010",

month = jun,

doi = "10.1016/j.euroneuro.2010.02.015",

language = "אנגלית",

volume = "20",

pages = "426--432",

journal = "European Neuropsychopharmacology",

issn = "0924-977X",

publisher = "Elsevier B.V.",

number = "6",

}

Baldwin, DS, Allgulander, C, Altamura, AC, Angst, J, Bandelow, B, den Boer, J, Boyer, P, Davies, S, dell'Osso, B, Eriksson, E, Fineberg, N, Fredrikson, M, Herran, A, Maron, E, Metspalu, A, Nutt, D, van der Wee, N, Vázquez-Barquero, JL & Zohar, J 2010, 'Manifesto for a European anxiety disorders research network', European Neuropsychopharmacology, vol. 20, no. 6, pp. 426-432. https://doi.org/10.1016/j.euroneuro.2010.02.015

TY - JOUR

T1 - Manifesto for a European anxiety disorders research network

AU - Baldwin, David S.

AU - Allgulander, Christer

AU - Altamura, Alfredo Carlo

AU - Angst, Jules

AU - Bandelow, Borwin

AU - den Boer, Johan

AU - Boyer, Patrice

AU - Davies, Simon

AU - dell'Osso, Bernardo

AU - Eriksson, Elias

AU - Fineberg, Naomi

AU - Fredrikson, Mats

AU - Herran, Andres

AU - Maron, Eduard

AU - Metspalu, Andres

AU - Nutt, David

AU - van der Wee, Nic

AU - Vázquez-Barquero, Jose Luis

AU - Zohar, Joseph

N1 - Funding Information: The ECNP Network Initiative (ECNP-NI) is supported financially by the ECNP. The Anxiety Disorders Research Network is one component of the ECNP-NI and has received funding from the ECNP-NI to support its initial development. Funding Information: The ECNP Network Initiative (ECNP-NI) is supported financially by the ECNP. The Anxiety Disorders Research Network is one component of the ECNP-NI and has received funding from the ECNP-NI to support its initial development. David Baldwin is the Chair of the ADRN and makes the following declaration: declarations from the other 18 members of the ADRN do not accompany this manuscript but would be made available upon request.

PY - 2010/6

Y1 - 2010/6

N2 - Despite the size, burden and costs of anxiety disorders, many patients remain unrecognised, and the effectiveness of evidence-based interventions in routine clinical practice can be disappointing. The European College of Neuropsychopharmacology (ECNP) has established the ECNP Network Initiative (ECNP-NI) to help meet the goal of extending current understanding of the causes of central nervous system disorders, thereby contributing to improvements in clinical outcomes and reducing the associated societal burden. The Anxiety Disorders Research Network (ADRN) has been adopted within the ECNP-NI: this consensus statement summarises its overall aims and objectives.

AB - Despite the size, burden and costs of anxiety disorders, many patients remain unrecognised, and the effectiveness of evidence-based interventions in routine clinical practice can be disappointing. The European College of Neuropsychopharmacology (ECNP) has established the ECNP Network Initiative (ECNP-NI) to help meet the goal of extending current understanding of the causes of central nervous system disorders, thereby contributing to improvements in clinical outcomes and reducing the associated societal burden. The Anxiety Disorders Research Network (ADRN) has been adopted within the ECNP-NI: this consensus statement summarises its overall aims and objectives.

KW - Anxiety disorders

KW - Outcomes

KW - Research network

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=77952550963&partnerID=8YFLogxK

U2 - 10.1016/j.euroneuro.2010.02.015

DO - 10.1016/j.euroneuro.2010.02.015

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

AN - SCOPUS:77952550963

SN - 0924-977X

VL - 20

SP - 426

EP - 432

JO - European Neuropsychopharmacology

JF - European Neuropsychopharmacology

IS - 6

ER -

Manifesto for a European anxiety disorders research network

Abstract

Funding

Keywords

Access to Document

Other files and links

Fingerprint

Cite this